<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>House of Commons Science and Technology Committee Inquiry into Blood, Tissue and Organ Screening and vCJD – Evidence submitted from the Serious Hazards of Transfusion Haemovigilance Scheme</title></head><body><div><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written e</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">vidence submitted </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">by</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold"> the Serious Hazards of Transfusion Haemovigilance Scheme</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold"> (BTO0029)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">1)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">This paper describes the national strategy for surveillance of adverse events related to blood transfusion and the resulting improvements in patient safety. Blood transfusion is very safe and effective when used appropriately.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">2)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Questions about blood safety emerged following the appearance of the acquired immune deficiency syndrome and discovery of its related virus (human immunodeficiency virus, HIV) in the 1980s.  Multiply transfused haemophilia patients treated with factor concentrates made from pooled plasma were noted</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the late 1970s</span><span style="font-family:'Times New Roman'; font-size:11pt"> to develop hepatitis transmitted from these products. </span><span style="font-family:'Times New Roman'; font-size:11pt">There was also concern that serious and potentially lethal errors (incompatible blood transfusions) were not reported.</span><span style="font-family:'Times New Roman'; font-size:11pt"> Therefore many countries decided to set up vigilance programmes. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">3)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The European Union</span><span style="font-family:'Times New Roman'; font-size:11pt"> published a series of Blood Safety Directives (2002-2005) which were transposed into the UK Blood Safety and Quality Regulations (BSQR) in 2005. The Medicines and Healthcare products Regulatory Agency (MHRA) was appointed as the Competent Authority to implement the EU Safety Directives. The BSQR focus on serious adverse reactions and events which must be reported by law to the EU. </span><span style="font-family:'Times New Roman'; font-size:11pt">The MHRA requires reporting of all serious reactions such as transfusion-transmitted infection or haemolysis, but also serious adverse events caused by a process failure in the quality management system in Blood Establishments and hospital transfusion laboratories regardless of whether the component was transfused, but the legislative remit extends only to the point where the transfusion laboratory reponsibility ends. Adverse events involving only clinical staff are not reportable under EU legislation but constitute the largest group of </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reports including avoidable or delayed transfusion, near miss events and mistakes with anti-D immunoglobulin administration to RhD negative women during and after pregnancy.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">4)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Haemovigilance is defined (by the International Haemovigilance Network)  as surveillance procedures covering the whole transfusion chain, from collection of blood and its components to follow-up of recipients, intended to collect and assess info</span><span style="font-family:'Times New Roman'; font-size:11pt">rmation on unexpected or undesir</span><span style="font-family:'Times New Roman'; font-size:11pt">able effects resulting from the therapeutic use of labile blood products and to prevent their occurrence or recurrence. </span><span style="font-family:'Times New Roman'; font-size:11pt">  Blood transfusion is a multistep process involving several different professional groups who need to work closely together (nursing staff, laboratory staff, medical staff, porters). The</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">UK</span><span style="font-family:'Times New Roman'; font-size:11pt"> national haemovigilance scheme, Serious Hazards of Transfusion (</span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt">) was set up in 1996</span><span style="font-family:'Times New Roman'; font-size:11pt">, prior to the introducion of the EU Directives, </span><span style="font-family:'Times New Roman'; font-size:11pt"> and now has reported annually for 16 years</span><span style="font-family:'Times New Roman'; font-size:11pt"> (17</span><span style="font-family:'Times New Roman'; font-size:7.33pt; vertical-align:super">th</span><span style="font-family:'Times New Roman'; font-size:11pt"> report currently being prepared)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> is funded by the 4 UK Blood Services and is affiliated to the Royal College of Pathologists.  Its activities are overseen by a steering group whose membership includes representatives from the Royal Colleges (medical and nursing) and other specialist societies.</span><span style="font-family:'Times New Roman'; font-size:11pt"> A full list is available on the </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> website (</span><a href="http://www.shotuk.org/home/terms-of-reference"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">www.shotuk.org/home/terms-of-reference</span></a><span style="font-family:'Times New Roman'; font-size:11pt"> ).</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">5)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> collects and analyses information on transfusion reactions and adverse events from all healthcare organisations in the </span><span style="font-family:'Times New Roman'; font-size:11pt">UK</span><span style="font-family:'Times New Roman'; font-size:11pt"> that are involved in blood transfusion.  </span><span style="font-family:'Times New Roman'; font-size:11pt">This includes transfusion of red cells, plasma, cryoprecipitate and platelet concentrates.  </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> works collaboratively with other bodies with responsibility for transfusion safety (e.g. the Medicines and Healthcare products Regulatory Agency (MHRA), the National Blood Transfusion Committee</span><span style="font-family:'Times New Roman'; font-size:11pt"> (set up in 2001)</span><span style="font-family:'Times New Roman'; font-size:11pt"> and its counterparts in Scotland, Wales and Northern Ireland, the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO), the National Patient Safety Agency, and the Department of Health Blood Policy</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">Unit).</span><span style="font-family:'Times New Roman'; font-size:11pt">  Reports required by the BSQR are submitted to the MHRA through their statutory SABRE online reporting system since 2005.  </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt">’s online reporting system shares a common portal – some events are only MHRA-reportable, others, particularly </span><span style="font-family:'Times New Roman'; font-size:11pt">many </span><span style="font-family:'Times New Roman'; font-size:11pt">clinical </span><span style="font-family:'Times New Roman'; font-size:11pt">incidents</span><span style="font-family:'Times New Roman'; font-size:11pt"> may only be </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt">–reportable and others require reporting to both schemes.  Reporters now enter demographic data once, and </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> and the MHRA are working towards a combined system.  The </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> Annual reports for 2011 and 2012 include a chapter describing the MHRA reports.  Meetings take place to reconcile the data (e.g.transfusion-related deaths, transfusion-transmitted infections).</span><span style="font-family:'Times New Roman'; font-size:11pt">  </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">6)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt">’s</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">mission is to improve patient safety in blood transfusion in the following ways: </span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 28.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Improve standards of hospital transfusion practice</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 28.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Educate users on transfusion hazards and their prevention</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 28.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Aid production of clinical guidelines</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 28.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Inform policy within the UK Blood Services</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 28.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Inform national policy on transfusion safety within the </span><span style="font-family:'Times New Roman'; font-size:11pt">UK</span></li></ul><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">7)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Reporting to SHOT was initially voluntary but is now required by several professional bodies</span><span style="font-family:'Times New Roman'; font-size:11pt"> (Clinical Pathology Accreditation, Nursing and Midwifery Council)</span><span style="font-family:'Times New Roman'; font-size:11pt"> and is mandatory for clinicians in line with the General Medical Council’s  standard for Good Medical Practice</span><span style="font-family:'Times New Roman'; font-size:11pt">, and the Francis Report</span><span style="font-family:'Times New Roman'; font-size:11pt">.  </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">8)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Reporting to </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> has increased steadily over the 17 years of reporting</span><span style="font-family:'Times New Roman'; font-size:11pt"> (data for 2013 currently under analysis)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> In </span><span style="font-family:'Times New Roman'; font-size:11pt">2012 99.5</span><span style="font-family:'Times New Roman'; font-size:11pt">% of all NHS Hospitals, Trusts and Health Boards were registered to report to </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt">, and 97.8% submitted reports (</span><span style="font-family:'Times New Roman'; font-size:11pt">total reports for 2012=</span><span style="font-family:'Times New Roman'; font-size:11pt">3545)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">9)</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Reports fall into </span><span style="font-family:'Times New Roman'; font-size:11pt">four</span><span style="font-family:'Times New Roman'; font-size:11pt"> main categories</span><span style="font-family:'Times New Roman'; font-size:11pt"> (cumulative number of reports 1996-2012 = 11570)</span><span style="font-family:'Times New Roman'; font-size:11pt">:</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Reactions and events which are unpredictable such as acute allergic reactions and immunological reactions to plasma and platelets</span><span style="font-family:'Times New Roman'; font-size:11pt">. This is a key reason for monitoring every transfusion in every patient.</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Transfusion-transmitted infections which are rare: a total of 69  (</span><span style="font-family:'Times New Roman'; font-size:11pt">0.6% of reports) </span><span style="font-family:'Times New Roman'; font-size:11pt">confirmed infections in 16 years of reporting (1996-2012 inclusive).</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Reactions which might be preventable by improved monitoring and better practice, such as transfusion-associated circulatory overload; some cases of irregular antibody development in people with sickle cell disease (improved selection of type of red cells).</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Reactions and events which result from mistakes in the transfusion process</span><span style="font-family:'Times New Roman'; font-size:11pt"> including wrong blood events which may be fatal</span><span style="font-family:'Times New Roman'; font-size:11pt">, more than 99% occurring in the hospital setting</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ul><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">10)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Overall, about half of all reported events are a result of mistakes. </span><span style="font-family:'Times New Roman'; font-size:11pt">Most of these do not result in serious consequences for the patient.</span><span style="font-family:'Times New Roman'; font-size:11pt"> Each year the report includes learning points and recommendations for changes in practice.  </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reporting has been instrumental in changing practice both at the Blood </span><span style="font-family:'Times New Roman'; font-size:11pt">Servic</span><span style="font-family:'Times New Roman'; font-size:11pt">es and in hospital</span><span style="font-family:'Times New Roman'; font-size:11pt"> laboratories and clinical areas</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span><span style="font-family:'Times New Roman'; font-size:11pt">  </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> thus alerts the NHS to transfusion safety issues which can be addressed in order to reduce the risks.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">11)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Examples of risk reduction by </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Blood </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Service</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> as a result of </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reporting and recommendations are:</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">A</span><span style="font-family:'Times New Roman'; font-size:11pt"> reduction in transfusion-related acute lung injury by moving to male donors for plasma in 2002</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and platelets</span><span style="font-family:'Times New Roman'; font-size:11pt"> from either male or leucocyte-antibody negative female donors</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">A</span><span style="font-family:'Times New Roman'; font-size:11pt"> reduction in bacterial transmission by diversion of the first </span><span style="font-family:'Times New Roman'; font-size:11pt">30-40</span><span style="font-family:'Times New Roman'; font-size:11pt"> mLs of the donation in 2002,  and improved skin cleansing). No bacterial transmissions have been reported to </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> since 201</span><span style="font-family:'Times New Roman'; font-size:11pt">0</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Recognition that most bacterial transmissions occurred from platelet concentrates, identifying the need for platelet bacterial screening which has now been introduced</span></li></ul><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">12)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reports are classified according to a </span><span style="font-family:'Times New Roman'; font-size:11pt">set of </span><span style="font-family:'Times New Roman'; font-size:11pt">definitions (</span><span style="font-family:'Times New Roman'; font-size:11pt">based on those published by</span><span style="font-family:'Times New Roman'; font-size:11pt"> the I</span><span style="font-family:'Times New Roman'; font-size:11pt">nternational </span><span style="font-family:'Times New Roman'; font-size:11pt">Society of B</span><span style="font-family:'Times New Roman'; font-size:11pt">lo</span><span style="font-family:'Times New Roman'; font-size:11pt">od T</span><span style="font-family:'Times New Roman'; font-size:11pt">ransfusion) and are analysed by members of a working expert group including transfusion specialists, hospital consultants and senior laboratory scientists whose expertise covers the different types of incidents. Analysis yields </span><span style="font-family:'Times New Roman'; font-size:11pt">trends and </span><span style="font-family:'Times New Roman'; font-size:11pt">features leading to the overall major recommendations in each annual report (such as weaknesses in patient identification, failure to perform the final bedside checks), specific recommendations in the different incident groups  as indicated above, and learning points for laboratory and clinical staff to improve their practice. The Annual Report is published at an annual symposium held in July where the findings are presented and discussed</span><span style="font-family:'Times New Roman'; font-size:11pt"> together with relevant transfusion topics</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> In addition 8-12 page booklets are produced alternate years summarising the main lessons, ‘Laboratory Lessons’ and ‘Clinical Lessons’.  These are distributed at meetings and teaching sessions</span><span style="font-family:'Times New Roman'; font-size:11pt"> and are available to download from the website in addition to the Annual Reports, their summaries and other resources</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">13)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Changes in </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">H</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">ospital </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">P</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">ractice</span><span style="font-family:'Times New Roman'; font-size:11pt"> resulting from </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reporting</span><span style="font-family:'Times New Roman'; font-size:11pt">: </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">14)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The demonstration every year that incorrect transfusions</span><span style="font-family:'Times New Roman'; font-size:11pt"> (e.g. wrong blood group, or missing specific requirements for that patient)</span><span style="font-family:'Times New Roman'; font-size:11pt"> make up the largest group of adverse events led to several initiatives.</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Th</span><span style="font-family:'Times New Roman'; font-size:11pt">e Department of Health Better Blood Transfusion</span><span style="font-family:'Times New Roman'; font-size:11pt"> circulars (1998, 2002 and 2007) which led to a co-ordinated national approach to improve transfusion practice with recommendations for education and training.</span><span style="font-family:'Times New Roman'; font-size:11pt"> SHOT staff teach in hospitals, at regional and local transfusion committee education days and at national and international meetings (25 abstracts in 2012-2013)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> The SHOT reports and case studies are used extensively for teaching within hospitals by nursing and laboratory staff.</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> data </span><span style="font-family:'Times New Roman'; font-size:11pt">informed </span><span style="font-family:'Times New Roman'; font-size:11pt">a number of areas for </span><span style="font-family:'Times New Roman'; font-size:11pt">further </span><span style="font-family:'Times New Roman'; font-size:11pt">guideline development in transfusion</span><span style="font-family:'Times New Roman'; font-size:11pt"> by the British Committee for Standards in Haematology; 24</span><span style="font-family:'Times New Roman'; font-size:11pt"> transfusion-related guidelines</span><span style="font-family:'Times New Roman'; font-size:11pt"> have been produced since 1996 (see </span><a href="http://www.bcshguidelines.com"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">www.bcshguidelines.com</span></a><span style="font-family:'Times New Roman'; font-size:11pt"> )</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The development of the Hospital Transfusion Practitioner role was encouraged and these professional staff are key in train</span><span style="font-family:'Times New Roman'; font-size:11pt">ing and reporting</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">SHOT recommendations have led to National Patient Safety Agency Safer Practice Notices</span><span style="font-family:'Times New Roman'; font-size:11pt"> (SPN) 11 </span><span style="font-family:'Times New Roman'; font-size:11pt">(2005) </span><span style="font-family:'Times New Roman'; font-size:11pt">concerning the importance of patient identification by wristbands,</span><span style="font-family:'Times New Roman'; font-size:11pt"> SPN 002 – the risk to patient safety of not using the NHS number,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and SPN 14</span><span style="font-family:'Times New Roman'; font-size:11pt"> (2006) </span><span style="font-family:'Times New Roman'; font-size:11pt"> ‘Right patient, Right blood’ which mandated competency assessments for transfusion</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The National Reporting and Learning System observations on delayed transfusion</span><span style="font-family:'Times New Roman'; font-size:11pt">s resulting in death or harm</span><span style="font-family:'Times New Roman'; font-size:11pt"> in an emergency in collaboration with SHOT resulted in the Rapid Response Report in 2010 instructing hospitals to review their emergency procedures and to report any delays to SHOT</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">recommended in 2002 that basic epidemiological research was needed. This resulted in</span><span style="font-family:'Times New Roman'; font-size:11pt"> the establishment of the National Comparative Audit programme in 2003 which has been instrumental in benchmarking practice on the use and administration of blood and blood products (several audits have been repeated and demonstrate improvements in practice</span><span style="font-family:'Times New Roman'; font-size:11pt">) see </span><a href="http://hospital.blood.co.uk/safe_use/clinical_audit/national%20comparative/index.asp"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">http://hospital.blood.co.uk/safe_use/clinical_audit/national comparative/index.asp</span></a><span style="font-family:'Times New Roman'; font-size:11pt">  </span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 19.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Errors in hospital laboratory practice identified in </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reports triggered the formation of the UK Transfusion Laboratory Collaborative who produced minimum standards for Transfusion Laboratories. These have been revised in 2013</span><span style="font-family:'Times New Roman'; font-size:11pt"> and are submitted for publication</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></li></ul><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">15)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Summary of data from the </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> report for events reported in 2011 and 2012</span></p><table cellspacing="0" cellpadding="0" style="border-collapse:collapse; margin-left:0pt"><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:90.45pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:184.3pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2011</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:187.35pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2012</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:90.45pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Deaths</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:184.3pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">8 (1 from delayed and inadequate transfusion, 3 transfusion-associated circulatory overload,  2 acute transfusion reactions, 1 infant with necrotising enterocolit</span><span style="font-family:'Times New Roman'; font-size:11pt">i</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt">)</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:187.35pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">9 (1 transfusion-associated graft-versus-host disease</span><span style="font-family:'Times New Roman'; font-size:11pt">*</span><span style="font-family:'Times New Roman'; font-size:11pt">, 2 haemolytic transfusion reactions, 6 transfusion-associated circulatory overload)</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:90.45pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Major Morbidity</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:184.3pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">117</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:187.35pt"><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">134</span></p></td></tr></table><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 9pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">There had been no reports of transfusion-associated graft-versus-host disease since 2001 and this death prompted a national review of practice with new recommendations and guidance (see Annual Report for 2012 for details at </span><a href="http://www.shotuk.org"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">www.shotuk.org</span></a><span style="font-family:'Times New Roman'; font-size:11pt"> )</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">16)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reporting has alerted the transfusion community that p</span><span style="font-family:'Times New Roman'; font-size:11pt">eople with sickle cell disease are at particular risk of adverse events, particularly haemolytic transfusion reactions with serious outcome (11/16, 68.8%</span><span style="font-family:'Times New Roman'; font-size:11pt"> experiencing death or major morbidity</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the three years</span><span style="font-family:'Times New Roman'; font-size:11pt"> 2010 to 2012).</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">17)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Patients receiving bone marrow transplants have been identified at risk for receiving wrong blood group transfusions leading to recommendations for better communication.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">18)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Mistakes occur because at every stage of the transfusion process the professionals involved do not </span><span style="font-family:'Times New Roman'; font-size:11pt">always </span><span style="font-family:'Times New Roman'; font-size:11pt">follow established procedures. This has been highlighted in </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reports and the recommendation made for a checklist to be used.</span><span style="font-family:'Times New Roman'; font-size:11pt">  This has not yet been widely adopted but is likely to improve safety of the key steps as has been demonstrated </span><span style="font-family:'Times New Roman'; font-size:11pt">by introduction of the WHO checklist </span><span style="font-family:'Times New Roman'; font-size:11pt">for surgery.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify"><br style="page-break-before:always; clear:both" /></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">19)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Key Messages</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Blood transfusion is extremely safe in the </span><span style="font-family:'Times New Roman'; font-size:11pt">UK</span><span style="font-family:'Times New Roman'; font-size:11pt"> with the risks of contracting bacterial or viral infection being very low indeed.</span><span style="font-family:'Times New Roman'; font-size:11pt">  </span><span style="font-family:'Times New Roman'; font-size:11pt">Haemovigilance has contributed to transfusion safety by flagging up dangerous practice as well as unpredictable events.</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The risk of major morbidity resulting from a mistake in 2012 was 5.9 per million components issued, compared risk of transfusion-transmitted infection of  1 per million.  The risk of major morbidity was highest for acute transfusion reactions at 23.6 and for transfusion-associated circulatory overload at 10.1.</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The overall risk of death from transfusion from 2012 data was 3.1 per million components issued, the greatest risk being from transfusion-associated circulatory overload at 2.1 per million and was 0.0 for transfusion-transmitted infection</span><span style="font-family:'Times New Roman'; font-size:11pt"> (TTI)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></li></ul><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">20)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The risk of transfusion-transmitted infection has diminished with time: </span></p><table cellspacing="0" cellpadding="0" style="border-collapse:collapse; margin-left:63pt"><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:47.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Year</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:115.5pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Total reports analysed</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:131.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Number of confirmed TTIs</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:84.3pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">%</span><span style="font-family:'Times New Roman'; font-size:11pt"> of reports</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:47.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">1996/7</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:115.5pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">142</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:131.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">8</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:84.3pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">5.6</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:47.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2003</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:115.5pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">458</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:131.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">9</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:84.3pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">1.9</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:47.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2009</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:115.5pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">1279</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:131.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:84.3pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">0.23</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:47.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2011</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:115.5pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">1815</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:131.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">0</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:84.3pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">0</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:47.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2012</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:115.5pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">1645</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:131.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:84.3pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">0.2</span></p></td></tr></table><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">21)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">In the early years of reporting, </span><span style="font-family:'Times New Roman'; font-size:11pt">overall </span><span style="font-family:'Times New Roman'; font-size:11pt">3</span><span style="font-family:'Times New Roman'; font-size:11pt">6</span><span style="font-family:'Times New Roman'; font-size:11pt">% of reports were of death or major morbidity</span><span style="font-family:'Times New Roman'; font-size:11pt"> (1996/7)</span><span style="font-family:'Times New Roman'; font-size:11pt"> but this has reduced to 8% and an increased number of hospitals</span><span style="font-family:'Times New Roman'; font-size:11pt"> are</span><span style="font-family:'Times New Roman'; font-size:11pt"> participating.</span><span style="font-family:'Times New Roman'; font-size:11pt"> In particular, the total number, deaths and serious outcomes from </span><span style="font-family:'Times New Roman'; font-size:11pt">ABO-incompatible red cell transfusions </span><span style="font-family:'Times New Roman'; font-size:11pt">has reduced with better transfusion practice. These are classified as ‘Never Events’ by the Department of Health. Major morbidity includes complications such as kidney failure or admission to intensive care</span><span style="font-family:'Times New Roman'; font-size:11pt">, or ventilation</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> Data from previous  5-year periods are shown in the table.</span></p><table cellspacing="0" cellpadding="0" style="border-collapse:collapse; margin-left:0pt"><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:59.4pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Time period</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Total ABO-incompatible transfusions</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Deaths from </span><span style="font-family:'Times New Roman'; font-size:11pt">ABO-</span><span style="font-family:'Times New Roman'; font-size:11pt">incompatible transfusions</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:132.7pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">Major morbidity from </span><span style="font-family:'Times New Roman'; font-size:11pt">ABO-</span><span style="font-family:'Times New Roman'; font-size:11pt">incompatible transfusions</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:59.4pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">1996-2001</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">126</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">9</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:132.7pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">34</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:59.4pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2002-2006</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">85</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">6</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:132.7pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">19</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:59.4pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2007-2011</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">52</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:132.7pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">16</span></p></td></tr><tr><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:59.4pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2012</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">10</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:135pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">0</span></p></td><td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:132.7pt"><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">4</span></p></td></tr></table><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">22)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Deaths where the transfusion was definitely</span><span style="font-family:'Times New Roman'; font-size:11pt"> or partly</span><span style="font-family:'Times New Roman'; font-size:11pt"> responsible numbered 8 in 2011 and 9 in 2012 and the incidence of major morbidity was 117 in 2011 and 134 in 2012.</span><span style="font-family:'Times New Roman'; font-size:11pt"> This increase has occurred due to better recognition that patients can develop </span><span style="font-family:'Times New Roman'; font-size:11pt">lung</span><span style="font-family:'Times New Roman'; font-size:11pt"> complications related to transfusion, particularly transfusion-related acute lung injury and transfusion-associated circulatory overload. </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reporting has drawn attention to these events, and advised an amend</span><span style="font-family:'Times New Roman'; font-size:11pt">ment to the BCSH Guidelines on Administration of B</span><span style="font-family:'Times New Roman'; font-size:11pt">lood</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">C</span><span style="font-family:'Times New Roman'; font-size:11pt">omponents</span><span style="font-family:'Times New Roman'; font-size:11pt"> to reduce the risks.</span><span style="font-family:'Times New Roman'; font-size:11pt"> This addendum was published in 2012.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">23)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Errors continue to put patients at risk, particularly failure to adhere to basic procedures for identification of the correct patient at the time of blood sampling and at the time of transfusion. Errors make up more than half of all events reported to </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt">  Human errors </span><span style="font-family:'Times New Roman'; font-size:11pt">relating to patient identification </span><span style="font-family:'Times New Roman'; font-size:11pt">can be reduced by bar-code technology</span><span style="font-family:'Times New Roman'; font-size:11pt"> (recommended by </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> in</span><span style="font-family:'Times New Roman'; font-size:11pt"> 2009</span><span style="font-family:'Times New Roman'; font-size:11pt">)</span><span style="font-family:'Times New Roman'; font-size:11pt"> to link patient identity to blood samples with a confirmation against the blood bag and wristband at the time of transfusion.  These methods have been demonstrated to reduce transfusion errors (evidence published from </span><span style="font-family:'Times New Roman'; font-size:11pt">Oxford</span><span style="font-family:'Times New Roman'; font-size:11pt">) but the uptake by hospitals has been limited by the costs.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">24)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Key recommendations from SHOT Annual Reports for 2011 and 2012</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">- ‘back to basics’</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">:</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Confirmation of identity at every stage of the transfusion process and good communication a</span><span style="font-family:'Times New Roman'; font-size:11pt">re essential to prevent errors</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Correct patient identification </span><span style="font-family:'Times New Roman'; font-size:11pt">should be a core clinical skill</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The use of a transfusion checklist is recommended</span><span style="font-family:'Times New Roman'; font-size:11pt"> (2009 and repeated in 2011 with a model available on the </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> website)</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">With the increasing movement of patients between wards and teams it is essential to have good communication and </span><span style="font-family:'Times New Roman'; font-size:11pt">written </span><span style="font-family:'Times New Roman'; font-size:11pt">handover</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Competency assessment must be underpinned by an adequate and assessable knowledge base by both laboratory and clinical staff</span></li><li style="font-family:Symbol; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 10.06pt; padding-left:7.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">A zero-tolerance policy is recommended for identification of all pathology samples, not just those related to transfusion</span></li></ul><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">25)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt">The full </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> reports can be found at </span><a href="http://www.shotuk.org/shot-reports/"><span style="color:#0000ff; font-family:'Times New Roman'; font-size:11pt; text-decoration:underline">www.shotuk.org/shot-reports/</span></a><span style="font-family:'Times New Roman'; font-size:11pt"> together with the shorter summaries</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">26)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> haemovigilance scheme is an international field leader</span><span style="font-family:'Times New Roman'; font-size:11pt"> because it was one of the earliest, has detailed analysis and trending. T</span><span style="font-family:'Times New Roman'; font-size:11pt">he data </span><span style="font-family:'Times New Roman'; font-size:11pt">are</span><span style="font-family:'Times New Roman'; font-size:11pt"> widely used at international as well as national levels.  Many countries have developed haemovigilance schemes, particularly in </span><span style="font-family:'Times New Roman'; font-size:11pt">Europe</span><span style="font-family:'Times New Roman'; font-size:11pt">, but the International Haemovigilance Network encourages all countries to set this up.  It is difficult to compare data between countries as data collection </span><span style="font-family:'Times New Roman'; font-size:11pt">and denominator data are variable</span><span style="font-family:'Times New Roman'; font-size:11pt">.  </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">27)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> collects ‘near miss’ events where no harm came to the patient, but important lessons are learned from these observations. For example, for every wrong transfusion resulting from a wrong blood sample, there are about 100 ‘near miss’ events where the error was recognised</span><span style="font-family:'Times New Roman'; font-size:11pt"> before any transfusion took place,</span><span style="font-family:'Times New Roman'; font-size:11pt"> for example because the blood group previously recorded </span><span style="font-family:'Times New Roman'; font-size:11pt">for the patient </span><span style="font-family:'Times New Roman'; font-size:11pt">was different</span><span style="font-family:'Times New Roman'; font-size:11pt"> to the one associated with the current blood sample</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:'Times New Roman'; font-size:11pt">28)</span><span style="font:7.0pt 'Times New Roman'">&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> produces benchmarking data </span><span style="font-family:'Times New Roman'; font-size:11pt">annually </span><span style="font-family:'Times New Roman'; font-size:11pt">for all participants</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> relating the number of reports to the </span><span style="font-family:'Times New Roman'; font-size:11pt">size of the organisation as defined by the number of </span><span style="font-family:'Times New Roman'; font-size:11pt">blood components issued, and grouped geographically.  These show that the range</span><span style="font-family:'Times New Roman'; font-size:11pt"> of medians</span><span style="font-family:'Times New Roman'; font-size:11pt"> is 0.69 to 1.21 for the number of reports per 1000 components issued</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the different sized organisations, with an overall range of 0 to 6.8</span><span style="font-family:'Times New Roman'; font-size:11pt"> reports</span><span style="font-family:'Times New Roman'; font-size:11pt">. European and Canadian data are similar with 0.2 to 7.07 reports per 1000 units transfused or issued to hospitals.  A WHO Global Forum in November 2012 in association with the International Soiety of Blood Transfusion and the International Haemovigilance Network had representation from 46 countries. There is variable development of haemovigilance schemes hindered in many countries by lack of resources but also by a cultural fear of reporting adverse incidents.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Declaration of Interests:</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">This report was prepared by Dr. Paula Bolton-Maggs, DM, FRCPath, FRCP,  Medical Director of the Serious Hazards of Transfusion National Haemovigilance Scheme, </span><span style="font-family:'Times New Roman'; font-size:11pt">SHOT</span><span style="font-family:'Times New Roman'; font-size:11pt"> Office, </span><span style="font-family:'Times New Roman'; font-size:11pt">Manchester</span><span style="font-family:'Times New Roman'; font-size:11pt">.  I am employed by NHS Blood and Transplant on behalf of the Blood  Services for </span><span style="font-family:'Times New Roman'; font-size:11pt">Wales</span><span style="font-family:'Times New Roman'; font-size:11pt">, </span><span style="font-family:'Times New Roman'; font-size:11pt">Scotland</span><span style="font-family:'Times New Roman'; font-size:11pt">, </span><span style="font-family:'Times New Roman'; font-size:11pt">Northern Ireland</span><span style="font-family:'Times New Roman'; font-size:11pt"> and </span><span style="font-family:'Times New Roman'; font-size:11pt">England</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span><span style="font-family:'Times New Roman'; font-size:11pt"> I have no conflict of interest in the preparation of this report.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">I receive occasional honoraria</span><span style="font-family:'Times New Roman'; font-size:11pt"> for attending advisory board meetings and consultancy fees</span><span style="font-family:'Times New Roman'; font-size:11pt"> from commercial companies</span><span style="font-family:'Times New Roman'; font-size:11pt"> (LFB-France and BPL-UK)</span><span style="font-family:'Times New Roman'; font-size:11pt"> in </span><span style="font-family:'Times New Roman'; font-size:11pt">relation to my expertise in an inherited blood clotting disorder, Factor XI deficiency.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">January 2013</span></p><p style="border-top-color:#d9d9d9; border-top-style:solid; border-top-width:0.5pt; font-size:10pt; line-height:115%; margin:0pt 0pt 10pt; padding-top:1pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">&#xa0;</span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 10pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p></div></body></html>